Paul R. McGuirk
- Molecular Biology
- Organic Chemistry top 5%
- Pharmacology top 5%
- Oncology
- Molecular Medicine top 5%
- Co-authors
- Thomas D. GootzNeil OsheroffAnthony MarfatPaul HelquistMegan J. RobinsonBarbara A. MartinJoaquím RocaSònia Trigueros
- Topics
- Cancer therapeutics and mechanisms (12 papers)Antibiotics Pharmacokinetics and Efficacy (10 papers)Ion Transport and Channel Regulation (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Biological Chemistry
- Partner nations
- United StatesSpain
In The Last Decade
Paul R. McGuirk
30 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 629
- Organic Chemistry 346
- Pharmacology 275
- Oncology 148
- Molecular Medicine 122
Countries citing papers authored by Paul R. McGuirk
This map shows the geographic impact of Paul R. McGuirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. McGuirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. McGuirk more than expected).
Fields of papers citing papers by Paul R. McGuirk
This network shows the impact of papers produced by Paul R. McGuirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. McGuirk. The network helps show where Paul R. McGuirk may publish in the future.
Co-authorship network of co-authors of Paul R. McGuirk
This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. McGuirk. A scholar is included among the top collaborators of Paul R. McGuirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. McGuirk. Paul R. McGuirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 18 | |
| 3 | 15 | |
| 4 | 19 | |
| 5 | 1 | |
| 6 | 191 | |
| 7 | 58 | |
| 8 | 28 | |
| 9 | 25 | |
| 10 | 37 | |
| 11 | 35 | |
| 12 | 24 | |
| 13 | 55 | |
| 14 | 13 | |
| 15 | 38 | |
| 16 | UseofInVitro Topoisomerase IIAssays forStudying Quinolone Antibacterial Agents | 2 |
| 17 | 74 | |
| 18 | 6 | |
| 19 | 0 | |
| 20 | 19 |
About Paul R. McGuirk
Paul R. McGuirk is a scholar working on Pharmacology, Toxicology and Pharmaceutical Science, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Ion Transport and Channel Regulation (5 papers). The work is most often cited by research in Toxicology (112 citations), Molecular Medicine (122 citations) and Pharmacology (275 citations). Paul R. McGuirk has collaborated with scholars based in United States and Spain. Frequent co-authors include Thomas D. Gootz, Neil Osheroff, Anthony Marfat, Paul Helquist, Megan J. Robinson, Barbara A. Martin, Joaquím Roca, Sònia Trigueros, D. W. Sumners and Javier Arsuaga. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.